Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
ENDRA Life Sciences develops advanced ultrasound-based platforms, primarily TAEUS, for non-invasive detection and monitoring of liver fat and metabolic diseases. Its core focus is on creating scalable, cost-effective diagnostic tools leveraging thermoacoustic technology, AI integration, and existing ultrasound systems. Serving pharmaceutical, clinical, and medical markets globally, the company aims to improve early diagnosis, disease management, and therapeutic monitoring for conditions like fatty liver disease and obesity.
This description was generated via AI from an annual report. Updated about 1 year ago.